Skip to main content

Table 3 Prevalence and odds ratio of coronary heart diseases across glycemic categories: Tehran Lipid and Glucose Study (phase IV: 2008–2011)

From: Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011

  Case/Total Crude prevalence % (95% CI) Age-standardized prevalence a % (95% CI) Crude
odds ratio
(95% CI)
Age and sex adjusted odds ratio (95% CI) Full-adjusted odds ratio b
(95% CI)
NFG/NGT 247/4422 5.59 (4.91–6.26) 6.39 (5.59–7.19) Reference Reference Reference
iIFG 105/1171 8.97 (7.33–10.60) 6.52 (5.23–7.82) 1.67 (1.31–2.11) 1.13 (0.88–1.45) 0.99 (0.76–1.27)
iIGT 45/404 11.14 (8.07–14.21) 7.00 (4.73–9.27) 2.12 (1.52–2.96) 1.17 (0.82–1.67) 0.95 (0.66–1.38)
IFG/IGT 64/465 13.76 (10.63–16.90) 8.04 (5.40–10.67) 2.70 (2.01–3.62) 1.38 (1.01–1.89) 1.07 (0.78–1.47)
NDM 98/529 18.53 (15.21–21.84) 8.74 (7.08–10.40) 3.84 (2.98–4.96) 1.83 (1.40–2.41) 1.40 (1.06–1.86)
KDM 191/727 26.27 (23.07–29.47) 14.26 (10.73–17.79) 6.02 (4.89–7.43) 2.83 (2.26–3.55) 1.91 (1.51–2.43)
Total 750/7718 9.72 (9.06–10.38) 7.71 (7.18–8.24) _ _ _
  1. NFG Normal fasting glucose, NGT Normal glucose tolerance, iIFG Isolated impaired fasting glucose, iIGT Isolated impaired glucose tolerance, IFG/IGT Both impaired fasting glucose and impaired glucose tolerance, NDM Newly diagnosed diabetes mellitus, KDM Known diabetes mellitus, CI Confidence interval
  2. aAge-standardized prevalence is calculated based on Iranian population distribution data from the National Consensus Bureau for Tehran province (2010)
  3. bAdjusted for age, sex, BMI, hypercholesterolemia, low high-density lipoprotein cholesterol, hypertension, family history of premature cardiovascular disease, and smoking status